All stock lists
Braskem SA (New York Stock Exchange:BAK)
BR · Delayed Price · Currency is USD
Basic Materials · Chemicals
1.10-0.60 (-35.29%)
Market cap
$438M
Health Score
Analyst consensus
Listed since
Jan 13, 1999
Website
Insider Score
––Not scored
BAK Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
BAK analyst forecast
BAK analyst consensus
Hold2 ratings
Buy 0 Hold 1 Sell 1
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
BAK 12-month price target
$1.50+36.4% upsideaverage of 1 firm
$1.50High
$1.50Low
Best analysts covering BAK
- UBS0%success rate · 1 call
- Citigroup0%success rate · 1 call
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
BAK analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| HSBC | Hold | $1.50 | -2.6% | Downgraded | 2026-09-28 | |
| — | UBS | Sell | — | — | Downgraded | 2026-09-16 |
| — | JP Morgan | Neutral | — | — | Downgraded | 2026-06-30 |
| — | Citigroup | Sell | — | — | Downgraded | 2026-06-26 |
| — | UBS | Neutral | — | — | Downgraded | 2025-09-26 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2025-08-27 |
| — | UBS | Buy | — | — | Upgraded | 2024-09-18 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2024-09-10 |
| — | Citigroup | Buy | — | — | Upgraded | 2024-08-20 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2024-05-24 |
| — | JP Morgan | Neutral | — | — | Downgraded | 2023-07-05 |
| — | Scotiabank | Sector Outperform | — | — | Upgraded | 2023-05-08 |
| — | Scotiabank | Sector Underperform | — | — | Downgraded | 2022-08-15 |
| — | HSBC | Buy | — | — | Upgraded | 2022-01-26 |
| — | Santander | Hold | — | — | Downgraded | 2021-12-14 |
| — | HSBC | Hold | — | — | Downgraded | 2021-04-22 |
| — | JP Morgan | Underweight | — | — | Downgraded | 2020-01-24 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2019-12-20 |
| — | JP Morgan | Neutral | — | — | Downgraded | 2015-05-20 |
| — | Citigroup | Buy | — | — | Upgraded | 2013-04-24 |
| — | Citigroup | Buy | — | — | Upgraded | 2013-04-23 |
BAK earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-27 | -0.98 | -0.48 | $3.10B | $3.06B |
| 2026-05-11 | 0.21 | 0.71 | $3.39B | $2.99B |
| 2026-08-13 | 1.68 | 1.65 | $4.32B | $4.22B |
| 2026-11-12 | 0.02 | 0.00 | $3.64B | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.